BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20190537)

  • 1. Genetic polymorphisms in the locus control region and promoter of GH1 are related to serum IGF-I levels and height in patients with isolated growth hormone deficiency and healthy controls.
    de Graaff LC; Argente J; van Meurs JB; Uitterlinden AG; Hokken-Koelega AC
    Horm Res Paediatr; 2010; 73(1):25-34. PubMed ID: 20190537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic and likely pathogenic genetic alterations and polymorphisms in growth hormone gene (GH1) and growth hormone releasing hormone receptor gene (GHRHR) in a cohort of isolated growth hormone deficient (IGHD) children in Sri Lanka.
    Sundralingam T; Tennekoon KH; de Silva S; De Silva S; Hewage AS
    Growth Horm IGF Res; 2017 Oct; 36():22-29. PubMed ID: 28910730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of human growth hormone-releasing hormone receptor (GHRHR) gene sequence variation to isolated severe growth hormone deficiency (ISGHD) and normal adult height.
    Camats N; Fernández-Cancio M; Carrascosa A; Andaluz P; Albisu MÁ; Clemente M; Gussinyé M; Yeste D; Audí L
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):564-74. PubMed ID: 22489751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the (CA)n repeat polymorphism of insulin-like growth factor-I and -202 A/C IGF-binding protein-3 promoter polymorphism with adult height in patients with severe growth hormone deficiency.
    Miletta MC; Scheidegger UA; Giordano M; Bozzola M; Pagani S; Bona G; Dattani M; Hindmarsh PC; Petkovic V; Oser-Meier M; Flück CE; Mullis PE
    Clin Endocrinol (Oxf); 2012 May; 76(5):683-90. PubMed ID: 22026507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human growth hormone 1 (GH1) gene expression: complex haplotype-dependent influence of polymorphic variation in the proximal promoter and locus control region.
    Horan M; Millar DS; Hedderich J; Lewis G; Newsway V; Mo N; Fryklund L; Procter AM; Krawczak M; Cooper DN
    Hum Mutat; 2003 Apr; 21(4):408-23. PubMed ID: 12655556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel GHRHR and GH1 mutations in patients with isolated growth hormone deficiency.
    Birla S; Khadgawat R; Jyotsna VP; Jain V; Garg MK; Bhalla AS; Sharma A
    Growth Horm IGF Res; 2016 Aug; 29():50-56. PubMed ID: 27114065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal recessive form of isolated growth hormone deficiency is more frequent than the autosomal dominant form in a Brazilian cohort.
    Lido AC; França MM; Correa FA; Otto AP; Carvalho LR; Quedas EP; Nishi MY; Mendonca BB; Arnhold IJ; Jorge AA
    Growth Horm IGF Res; 2014 Oct; 24(5):180-6. PubMed ID: 25116472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type IA isolated growth hormone deficiency (IGHD) consistent with compound heterozygous deletions of 6.7 and 7.6 Kb at the GH1 gene locus.
    Keselman A; Scaglia PA; Rodríguez Prieto MS; Ballerini MG; Rodríguez ME; Ropelato MG; Bergadá I; Jasper HG; Domené HM
    Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):558-63. PubMed ID: 23295298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the spectrum of mutations in GH1 and GHRHR: genetic screening in a large cohort of patients with congenital isolated growth hormone deficiency.
    Alatzoglou KS; Turton JP; Kelberman D; Clayton PE; Mehta A; Buchanan C; Aylwin S; Crowne EC; Christesen HT; Hertel NT; Trainer PJ; Savage MO; Raza J; Banerjee K; Sinha SK; Ten S; Mushtaq T; Brauner R; Cheetham TD; Hindmarsh PC; Mullis PE; Dattani MT
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3191-9. PubMed ID: 19567534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A homozygous point mutation in the GH1 promoter (c.-223C>T) leads to reduced GH1 expression in siblings with isolated GH deficiency (IGHD).
    Madeira JL; Jorge AA; Martin RM; Montenegro LR; Franca MM; Costalonga EF; Correa FA; Otto AP; Arnhold IJ; Freitas HS; Machado UF; Mendonca BB; Carvalho LR
    Eur J Endocrinol; 2016 Aug; 175(2):K7-K15. PubMed ID: 27252485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer.
    Wagner K; Hemminki K; Israelsson E; Grzybowska E; Klaes R; Chen B; Butkiewicz D; Pamula J; Pekala W; Försti A
    Endocr Relat Cancer; 2005 Dec; 12(4):917-28. PubMed ID: 16322331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human growth hormone (GH1) gene polymorphism map in a normal-statured adult population.
    Esteban C; Audí L; Carrascosa A; Fernández-Cancio M; Pérez-Arroyo A; Ulied A; Andaluz P; Arjona R; Albisu M; Clemente M; Gussinyé M; Yeste D
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):258-68. PubMed ID: 17223997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p.R209H GH1 variant challenges short stature assessment.
    Sanguineti N; Braslavsky D; Scaglia PA; Keselman A; Ballerini MG; Ropelato MG; Suco S; Vishnopolska S; Berenstein AJ; Jasper H; Domené HM; Rey RA; Pérez Millán MI; Camper SA; Bergadá I
    Growth Horm IGF Res; 2020 Feb; 50():23-26. PubMed ID: 31835104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between vitamin D receptor (VDR) polymorphisms and the efficacy of recombinant human growth hormone (rhGH) treatment in children with idiopathic short stature.
    Wang W; Luo XP; Cai LX; Cui ZR; Luo XY; Luo RK
    Genet Mol Res; 2015 Sep; 14(3):10507-14. PubMed ID: 26400282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common polymorphisms in the GH/IGF-1 axis contribute to growth in extremely tall subjects.
    Hendriks AE; Brown MR; Boot AM; Oostra BA; de Jong FH; Drop SL; Parks JS
    Growth Horm IGF Res; 2011 Dec; 21(6):318-24. PubMed ID: 21944866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated Growth Hormone Deficiency Type 2 due to a novel
    Kautsar A; Wit JM; Pulungan A
    J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):426-431. PubMed ID: 30678423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GH1 gene deletions and IGHD type 1A.
    Cogan JD; Phillips JA
    Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():480-8. PubMed ID: 17551470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic screening of a Dutch population with isolated GH deficiency (IGHD).
    de Graaff LC; Argente J; Veenma DC; Herrebout MA; Friesema EC; Uitterlinden AG; Drent ML; Campos-Barros A; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 May; 70(5):742-50. PubMed ID: 18785993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splice site mutations in GH1 detected in previously (Genetically) undiagnosed families with congenital isolated growth hormone deficiency type II.
    Kempers MJ; van der Crabben SN; de Vroede M; Alfen-van der Velden J; Netea-Maier RT; Duim RA; Otten BJ; Losekoot M; Wit JM
    Horm Res Paediatr; 2013; 80(6):390-6. PubMed ID: 24280736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional common polymorphism in the vitamin D-responsive element of the GH1 promoter contributes to isolated growth hormone deficiency.
    Giordano M; Godi M; Mellone S; Petri A; Vivenza D; Tiradani L; Carlomagno Y; Ferrante D; Arrigo T; Corneli G; Bellone S; Giacopelli F; Santoro C; Bona G; Momigliano-Richiardi P
    J Clin Endocrinol Metab; 2008 Mar; 93(3):1005-12. PubMed ID: 18160466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.